We are live on
!
Find out more
E Fund Management Portfolio holdings
AUM
$4.46B
Turnover
13.19%
This Fund
S&P 500
This Quarter
Est. Return
+11.44%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.81B
AUM Growth
+$194M
(+12%)
Cap. Flow
+$40.5M
Cap. Flow
% of AUM
2.24%
Top 10 Holdings %
Top 10 Hldgs %
63.7%
Holding
392
New
24
Increased
176
Reduced
102
Closed
74
Avg Time Held
2.1
years
Top 10 Avg Time Held
1.1
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Futu Holdings
FUTU
|
+$32.5M |
| 2 |
Applied Materials
AMAT
|
+$26.5M |
| 3 |
Apple
AAPL
|
+$13.7M |
| 4 |
Microsoft
MSFT
|
+$11.9M |
| 5 |
NVIDIA
NVDA
|
+$9.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$28.3M |
| 2 |
KE Holdings
BEKE
|
+$13.2M |
| 3 |
TSMC
TSM
|
+$13.2M |
| 4 |
ASE Group
ASX
|
+$7.59M |
| 5 |
iQIYI
IQ
|
+$6.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 39.73% |
| 2 | Technology | 31.74% |
| 3 | Communication Services | 9.52% |
| 4 | Healthcare | 5.08% |
| 5 | Financials | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Centene
CNC
$34.4B
| $219K | 0.01% |
3,309
+199
| +6% | +$14.5K |
2023 Q4
2 quarters
|
|
277
Goldman Sachs
GS
$259B
| $219K | 0.01% |
484
-9
| -2% | -$3.95K |
2024 Q1
1 quarter
|
|
278
Denali Therapeutics
DNLI
$2.8B
| $214K | 0.01% |
9,200
-11,352
| -55% | -$218K |
2022 Q1
9 quarters
|
|
279
DELISTED
Dynavax Technologies
DVAX
| $213K | 0.01% |
18,929
-14,051
| -43% | -$164K |
2021 Q4
10 quarters
|
|
280
Mettler-Toledo International
MTD
$32.7B
| $211K | 0.01% |
151
-18
| -11% | -$24.6K |
2023 Q4
2 quarters
|
|
281
West Pharmaceutical
WST
$27B
| $209K | 0.01% |
634
+21
| +3% | +$7.42K |
2024 Q1
1 quarter
|
|
282
Union Pacific
UNP
$171B
| $209K | 0.01% |
922
| – | – |
2023 Q4
2 quarters
|
|
283
Zimmer Biomet
ZBH
$18.1B
| $208K | 0.01% |
1,917
+189
| +11% | +$22.3K |
2024 Q1
1 quarter
|
|
284
AT&T
T
$162B
| $207K | 0.01% |
10,815
| – | – |
2024 Q1
1 quarter
|
|
285
Teledyne Technologies
TDY
$28.7B
| $206K | 0.01% |
+532
| New | +$211K |
2024 Q2
0 quarters
|
|
286
Steris
STE
$21.7B
| $206K | 0.01% |
939
+20
| +2% | +$4.34K |
2024 Q1
1 quarter
|
|
287
ConocoPhillips
COP
$174B
| $204K | 0.01% |
1,782
| – | – |
2021 Q4
10 quarters
|
|
288
Cardinal Health
CAH
$58.9B
| $202K | 0.01% |
2,054
+159
| +8% | +$16.2K |
2024 Q1
1 quarter
|
|
289
DELISTED
Hologic
HOLX
| $202K | 0.01% |
2,715
+66
| +2% | +$4.95K |
2024 Q1
1 quarter
|
|
290
RTX Corp
RTX
$258B
| $201K | 0.01% |
+2,007
| New | +$208K |
2024 Q2
0 quarters
|
|
291
Novavax
NVAX
$1.86B
| $201K | 0.01% |
15,904
-63,610
| -80% | -$640K |
2022 Q1
9 quarters
|
|
292
Agios Pharmaceuticals
AGIO
$1.9B
| $201K | 0.01% |
4,668
-5,785
| -55% | -$209K |
2024 Q1
1 quarter
|
|
293
American Express
AXP
$214B
| $200K | 0.01% |
+865
| New | +$200K |
2024 Q2
0 quarters
|
|
294
Viatris
VTRS
$21.2B
| $199K | 0.01% |
18,762
+2,275
| +14% | +$25.1K |
2021 Q3
11 quarters
|
|
295
ADMA Biologics
ADMA
$2.38B
| $190K | 0.01% |
16,998
-15,243
| -47% | -$128K |
2022 Q3
7 quarters
|
|
296
Recursion Pharmaceuticals
RXRX
$1.95B
| $181K | 0.01% |
24,165
-14,562
| -38% | -$127K |
2022 Q3
7 quarters
|
|
297
DELISTED
Warner Bros
WBD
| $178K | 0.01% |
23,941
+538
| +2% | +$4.31K |
2022 Q4
6 quarters
|
|
298
BioCryst Pharmaceuticals
BCRX
$2.01B
| $175K | 0.01% |
28,285
-45,895
| -62% | -$253K |
2021 Q1
13 quarters
|
|
299
DELISTED
Catalyst Pharmaceutical
CPRX
| $175K | 0.01% |
11,266
-11,737
| -51% | -$183K |
2022 Q1
9 quarters
|
|
300
ImmunityBio
IBRX
$9.94B
| $167K | 0.01% |
26,458
-35,464
| -57% | -$234K |
2023 Q4
2 quarters
|
|
Similar funds
E Fund Management's Q2 2024 Portfolio in Review
As of Q2 2024, E Fund Management held 392 positions worth $1.81B, up 12% from $1.61B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
E Fund Management's Q2 2024 filing shows 24 new, 176 increased, 102 reduced and 74 closed positions. Its largest new stake was Futu Holdings: 480,000 shares worth $31.5M. The largest sale was Advanced Micro Devices, an estimated $28.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 40% of assets, down from 40% a quarter earlier, followed by Technology and Communication Services.
- E Fund Management's largest Q2 2024 buy was Futu Holdings: 480,000 shares worth $31.5M.
- E Fund Management added most to Applied Materials in Q2 2024, an estimated $26.5M increase.
- E Fund Management's biggest Q2 2024 reduction was Advanced Micro Devices, cutting an estimated $28.3M.
- E Fund Management fully exited Yum China in Q2 2024, selling an estimated $5.17M.
- E Fund Management's ten largest holdings make up 64% of its $1.81B portfolio in Q2 2024.
- E Fund Management opened 24 new positions and closed 74 in Q2 2024.
- E Fund Management's portfolio value rose 12% quarter-over-quarter to $1.81B.
Based on E Fund Management's 13F filing for Q2 2024, filed 12 Aug 2024.